tiprankstipranks
Trending News
More News >

AFT Pharmaceuticals Announces Director’s Shareholding Change Due to Inheritance

Story Highlights
AFT Pharmaceuticals Announces Director’s Shareholding Change Due to Inheritance

Don’t Miss TipRanks’ Half-Year Sale

An update from AFT Pharmaceuticals Ltd. ( (AU:AFP) ) is now available.

AFT Pharmaceuticals Ltd. announced a change in the shareholding of its director, Hartley Campbell Atkinson, due to an inheritance from the estate of Mrs. IJ Atkinson. This transaction involved the acquisition of 17,755 ordinary shares at zero consideration, slightly increasing Atkinson’s stake in the company. This development reflects internal adjustments within the company’s leadership and may have implications for its governance and shareholder structure.

More about AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd. operates in the pharmaceutical industry, focusing on the development and sale of pharmaceutical products. The company is known for its over-the-counter medicines and prescription drugs, serving both domestic and international markets.

Average Trading Volume: 3,079

Technical Sentiment Signal: Sell

Current Market Cap: A$246.8M

For an in-depth examination of AFP stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1